Artelo Biosciences, Inc. (ARTL)
5.15
+0.71
(+15.99%)
USD |
NASDAQ |
Apr 20, 09:44
Artelo Biosciences SG&A Expense (Quarterly) : 1.893M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 19.29M |
| GlucoTrack, Inc. | 1.86M |
| Ovid Therapeutics, Inc. | 6.422M |
| Apellis Pharmaceuticals, Inc. | 147.10M |
| Gossamer Bio, Inc. | 10.90M |